LEP and osteoporosis: Rodent data and more importantly, successful small scaled trials for both hypothalamic amenorrhea and osteoporosis (Welt et al., 2004; Sienkiewicz et al., 2011) in young and lean females suggest that the risks inherent to treatment with leptin are manageable, if adequate safety precautions are met.